Your browser doesn't support javascript.
loading
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial.
Yamada, Y; Denda, T; Gamoh, M; Iwanaga, I; Yuki, S; Shimodaira, H; Nakamura, M; Yamaguchi, T; Ohori, H; Kobayashi, K; Tsuda, M; Kobayashi, Y; Miyamoto, Y; Kotake, M; Shimada, K; Sato, A; Morita, S; Takahashi, S; Komatsu, Y; Ishioka, C.
Afiliação
  • Yamada Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Denda T; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
  • Gamoh M; Department of Medical Oncology, Osaki Citizen Hospital, Miyagi, Japan.
  • Iwanaga I; Department of Medical Oncology, Japanese Red Cross Kitami Hospital, Hokkaido, Japan.
  • Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan.
  • Shimodaira H; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Nakamura M; Comprehensive Cancer Center, Aizawa Hospital, Nagano, Japan.
  • Yamaguchi T; Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Ohori H; Clinical Oncology, Japanese Red Cross Ishinomaki Hospital, Miyagi, Japan.
  • Kobayashi K; Division of Medical Oncology, Showa University Northern Yokohama Hospital, Kanagawa, Japan.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Hyogo, Japan.
  • Kobayashi Y; Department of Internal Medicine, Kushiro Rosai Hospital, Hokkaido, Japan.
  • Miyamoto Y; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
  • Kotake M; Department of Surgery, Kouseiren Takaoka Hospital, Toyama, Japan.
  • Shimada K; Department of Internal Medicine, Showa University Koto Toyosu Hospital, Tokyo, Japan.
  • Sato A; Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Takahashi S; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Komatsu Y; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan. Electronic address: ykomatsu@ac.cyberhome.ne.jp.
  • Ishioka C; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
Ann Oncol ; 29(3): 624-631, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29293874
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão